66 related articles for article (PubMed ID: 20153897)
1. Thiopurine S-methyltransferase gene polymorphism and 6-mercaptopurine dose intensity in Indian children with acute lymphoblastic leukemia.
Kapoor G; Sinha R; Naithani R; Chandgothia M
Leuk Res; 2010 Aug; 34(8):1023-6. PubMed ID: 20153897
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of 6-mercaptopurine in a black Zimbabwean cohort treated for acute lymphoblastic leukaemia.
Chikondowa P; Munkombwe D; Chikwambi Z; Kuona P; Masimirembwa C
Pharmacogenomics; 2023 Jun; 24(8):449-457. PubMed ID: 37248698
[TBL] [Abstract][Full Text] [Related]
3. Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populations.
Maillard M; Nishii R; Yang W; Hoshitsuki K; Chepyala D; Lee SHR; Nguyen JQ; Relling MV; Crews KR; Leggas M; Singh M; Suang JLY; Yeoh AEJ; Jeha S; Inaba H; Pui CH; Karol SE; Trehan A; Bhatia P; Antillon Klussmann FG; Bhojwani D; Haidar CE; Yang JJ
J Natl Cancer Inst; 2024 May; 116(5):702-710. PubMed ID: 38230823
[TBL] [Abstract][Full Text] [Related]
4. Novel variant in Nudix hydrolase 15 gene influences 6-mercaptopurine toxicity in childhood acute lymphoblastic leukemia patients.
Sabirova Z; Mahnoor S; Lasfar D; Gagné V; Théorêt Y; Leclerc JM; Laverdière C; Sinnett D; Tran TH; Krajinovic M
Pharmacogenet Genomics; 2024 Jul; 34(5):170-173. PubMed ID: 38682355
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of FTO polymorphism in 6-mercaptopurine related intolerance in children with acute lymphoblastic leukemia.
Singh M; Bhaskar D; Bhatia P; Thakur R; Sharma P; Bansal D; Jain R; Trehan A
Cancer Chemother Pharmacol; 2023 Jul; 92(1):51-56. PubMed ID: 37256334
[TBL] [Abstract][Full Text] [Related]
6. Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia.
Stanulla M; Schaeffeler E; Möricke A; Buchmann S; Zimmermann M; Igel S; Schmiegelow K; Flotho C; Hartmann H; Illsinger S; Sauerbrey A; Junk SV; Schütte P; Hinze L; Lauten M; Modlich S; Kolb R; Rossig C; Schwabe G; Gnekow AK; Fleischhack G; Schlegel PG; Schünemann HJ; Kratz CP; Cario G; Schrappe M; Schwab M
Leukemia; 2021 Sep; 35(9):2650-2657. PubMed ID: 33714975
[TBL] [Abstract][Full Text] [Related]
7. Individualized Use of 6-Mercaptopurine in Chinese Children with ALL: A Multicenter Randomized Controlled Trial.
Zhou Y; Wang L; Sun LR; Zhang L; Wang HM; Liu XT; Yang F; Wu KL; Liang YL; Zhao BB; Zhuang Y; Fu JQ; Song C; Li Y; Wang LZ; Xu HJ; Gu Y; van den Anker J; Ju XL; Zhu XF; Zhao W
Clin Pharmacol Ther; 2024 Feb; 115(2):213-220. PubMed ID: 37753808
[TBL] [Abstract][Full Text] [Related]
8. Thiopurine S-methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction or cessation of 6-mercaptopurine doses during maintenance therapy: the Polish multicenter analysis.
Peregud-Pogorzelski J; Tetera-Rudnicka E; Kurzawski M; Brodkiewicz A; Adrianowska N; Mlynarski W; Januszkiewicz D; Drozdzik M
Pediatr Blood Cancer; 2011 Oct; 57(4):578-82. PubMed ID: 21319286
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants of thiopurine and folate metabolic pathways determine 6-MP-mediated hematological toxicity in childhood ALL.
Dorababu P; Naushad SM; Linga VG; Gundeti S; Nagesh N; Kutala VK; Reddanna P; Digumarti R
Pharmacogenomics; 2012 Jul; 13(9):1001-8. PubMed ID: 22838948
[TBL] [Abstract][Full Text] [Related]
10. Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management.
Parikh SA; Tefferi A
Am J Hematol; 2013 Nov; 88(11):967-74. PubMed ID: 23963888
[TBL] [Abstract][Full Text] [Related]
11. Thiopurine S-methyltransferase alleles, TPMT(*)2, (*)3B and (*)3C, and genotype frequencies in an Indian population.
Murugesan R; Vahab SA; Patra S; Rao R; Rao J; Rai P; Gopinath PM; Satyamoorthy K
Exp Ther Med; 2010 Jan; 1(1):121-127. PubMed ID: 23136604
[TBL] [Abstract][Full Text] [Related]
12. Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia.
Chrzanowska M; Kuehn M; Januszkiewicz-Lewandowska D; Kurzawski M; Droździk M
Acta Pol Pharm; 2012; 69(3):405-10. PubMed ID: 22594254
[TBL] [Abstract][Full Text] [Related]
13.
Jantararoungtong T; Wiwattanakul S; Tiyasirichokchai R; Prommas S; Sukprasong R; Koomdee N; Jinda P; Rachanakul J; Nuntharadthanaphong N; Pakakasama S; Anurathapan U; Hongeng S; Sukasem C
J Pers Med; 2021 Aug; 11(8):. PubMed ID: 34442427
[TBL] [Abstract][Full Text] [Related]
14.
Rosdiana DS; Setiabudy R; Andalusia R; Gatot D; Louisa M; Bardosono S; Instiaty I
Pharmgenomics Pers Med; 2021; 14():199-210. PubMed ID: 33568932
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of the impact of thioprine
Kim MG; Ko M; Kim IW; Oh JM
Onco Targets Ther; 2016; 9():7133-7139. PubMed ID: 27920553
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use.
Mlakar V; Huezo-Diaz Curtis P; Satyanarayana Uppugunduri CR; Krajinovic M; Ansari M
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618021
[TBL] [Abstract][Full Text] [Related]
17. Thiopurine methyltransferase polymorphisms in children with acute lymphoblastic leukemia.
Linga VG; Patchva DB; Mallavarapu KM; Tulasi V; Kalpathi KI; Pillai A; Gundeti S; Rajappa SJ; Digumarti R
Indian J Med Paediatr Oncol; 2014 Oct; 35(4):276-80. PubMed ID: 25538405
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia.
Farfan MJ; Salas C; Canales C; Silva F; Villarroel M; Kopp K; Torres JP; Santolaya ME; Morales J
BMC Cancer; 2014 Apr; 14():299. PubMed ID: 24774509
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
